Abstract. Equine chorionic gonadotrophin (eCG) has been widely used in superovulation and artificial insemination programmes and usually promotes an increase in corpus luteum (CL) volume and stimulates progesterone production. Therefore, to identify eCG-regulated genes in the bovine CL, the transcriptome was evaluated by microarray analysis and the expression of selected genes was validated by qPCR and western blot. Eighteen Nelore crossbred cows were divided into control (n ¼ 5), stimulated (n ¼ 6) and superovulated groups (n ¼ 7). Ovulation was synchronised using a progesterone device-based protocol. Stimulated animals received 400 IU of eCG at device removal and superovulated animals received 2000 IU of eCG 4 days prior. Corpora lutea were collected 7 days after gonadotrophin-releasing hormone administration. Overall, 242 transcripts were upregulated and 111 transcripts were downregulated in stimulated cows (P # 0.05) and 111 were upregulated and 113 downregulated in superovulated cows compared to the control animals (1.5-fold, P # 0.05). Among the differentially expressed genes, many were involved in lipid biosynthesis and progesterone production, such as PPARG, STAR, prolactin receptors and follistatin. In conclusion, eCG modulates gene expression differently depending on the treatment, i.e. stimulatory or superovulatory. Our data contribute to the understanding of the pathways involved in increased progesterone levels observed after eCG treatment.
Introduction
The use of biotechnology to improve reproductive efficiency is prevalent in cattle, especially techniques directed towards ovarian follicle growth and manipulation of conception rates. Different strategies have been proposed to improve the responses to timed artificial insemination, such as the use of equine chorionic gonadotrophin (eCG) to stimulate follicle growth, progesterone (P4) production and conception rates (Bó et al. 2002; Sá Filho et al. 2010; Sales et al. 2011) . Furthermore, eCG has been employed in various superovulatory protocols to increase the number of embryos produced per donor cow ) and this technique renders it possible to disseminate high genetic quality and improve the reproductive performance in cattle (Ambrose et al. 1999; Hansen et al. 2001; Baruselli et al. 2011) . Derived from the equine fetal chorion, eCG is a glycoprotein that binds to both LH and FSH receptors in species other than the horse (Murphy and Martinuk 1991) and can therefore activate multiple signal transduction pathways in the ovary. Treatments using eCG can improve corpus luteum (CL) volume, which is usually associated with increases in progesterone concentration (Binelli et al. 2001; Sá Filho et al. 2010; Baruselli et al. 2011; Fields et al. 2012) . Progesterone plays a key role in reproductive events associated with the establishment and maintenance of pregnancy via P4-induced changes in the endometrial transcriptome (Clemente et al. 2009 ). Luteotrophic hormones can also modulate luteal synthesis of cytokines and growth factors, such as vascular endothelial growth factor (VEGF; Papa et al. 2007) , the insulin-like growth factors (IGFs; Juengel et al. 1997 ) and many other elements that can influence luteal cell function (Devoto et al. 2000; Webb et al. 2002) .
The differentiation of follicular granulosa cells into large luteal cells is associated with marked changes in metabolic function, including an increase in mitochondrial enzyme activity (Doody et al. 1990; Richards and Almond 1994) , necessary to supply energy for steroid production. The first step in progesterone synthesis is the conversion of cholesterol to pregnenolone by cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1/P450scc), which is located in the inner mitochondrial membrane (Miller 1988; Niswender and Nett 1994; . Pregnenolone can then be converted to progesterone by hydroxy-delta-5-steroid dehydrogenase 3b (HSD3B), which is present in the smooth endoplasmic reticulum (Labrie et al. 1992) . The initial challenge for steroidogenesis as well as its rate-limiting step is to transport the hydrophobic parent molecule cholesterol from the outer to the inner mitochondrial membrane under the influence of the steroidogenic acute regulatory protein (STAR), which is acutely induced by luteotrophic hormones (Stocco et al. 2001) . Luteal cells can obtain cholesterol through cholesterol-rich lowdensity lipoprotein (LDL) endocytosis or through selective uptake of high-density lipoprotein (HDL) cholesterol esters (Brannian and Stouffer 1993) . In addition, de novo cholesterol synthesis contributes to the intracellular cholesterol load and this synthesis is controlled by luteotrophic hormones (Golos and Strauss 1988) . In cows, fatty-acid precursor availability is coupled with an increase in sexual steroid levels (Garcia-Bojalil et al. 1998) . Cholesterol homeostasis is central to adequate CL function and might involve several factors, such as peroxisome proliferator-activated receptors (PPARs), which are key transcription factors in lipid metabolism regulation (Komar 2005; Varga et al. 2011) .
It is well established that CL function requires coordinated actions between luteotrophic hormones, growth factors and steroidogenic proteins (Niswender 2002) , as well as cellular lipid biosynthesis and homeostasis (Kliewer et al. 1997; Christenson and Devoto 2003) . Because it has been previously reported that eCG increased CL volume and P4 production in cows (Bó et al. 2002; Sá Filho et al. 2010; Sales et al. 2011) , we hypothesised that eCG regulates the expression of genes involved in luteal development and in the steroidogenic process. Therefore, this work was designed to analyse the effects of eCG on global gene expression in bovine CL by microarray, focusing on steroidogenesis-related protein expression, to gain further insights into the progesterone increases observed after stimulatory and superovulatory treatments.
Material and methods

Animals and tissue collection procedures
All procedures were approved by the Committee in Ethics for the Use of Experimental Animals of the Faculty of Veterinary Medicine and Animal Sciences, University of São Paulo, Brazil, under protocol number 1638/2009. Eighteen Nelore crossbred cows aged between 2 and 5 years were used. The animals were maintained on pasture and supplemented with cornmeal (17.03%), soybean meal (4.65%), urea (1.13%), ammonium sulfate (0.11%), minerals (1.69%), salt (0.53%) and corn silage (74.86%). Before the trial period, cows were evaluated for their body condition score on a scale of 1 to 5 (Wildman 1982) and for their ovarian status by rectal palpation, as described by Madureira (2004) ; animals showing a condition score between 2.0 and 3.0 with functional ovaries were selected.
Hormonal treatments
Cows were randomly distributed into three groups (control, n ¼ 5; stimulated, n ¼ 6 and superovulated, n ¼ 7; Fig. 1 ). Briefly, on Day 0 (random day of the oestrous cycle) all animals received an intravaginal device containing 1 g of progesterone (Primer, Technopec, São Paulo, Brazil) and an intramuscular injection of 2 mg of oestradiol benzoate (Estrogin; Farmavet, São Paulo, Brazil). On Day 8, the intravaginal devices were removed from the control and stimulated cows and 0.150 mg of d-cloprostenol (prostaglandin (PGF) 2a, Prolise; Arsa, Buenos Aires, Argentina) was administered. The control cows did not receive eCG (Novormon; Syntex, Buenos Aires, Argentina), whereas the stimulated cows received 400 IU on Day 8, which is considered to be the optimal dose to improve dominant follicles (Sa Filho et al. 2010; Sales et al. 2011) . At 48 h following device removal, control and stimulated cows received 0.025 mg of lecirelin (gonadotrophin-releasing hormone (GnRH), Gestran Plus; Arsa). Cows submitted to superovulatory treatment, which aimed to increase the number of ovulated follicles, received 2000 IU of eCG on Day 4 and 0.150 mg of PGF2a on Day 6 . On Day 7, the devices were removed and a second dose of PGF2a was administered. Twelve hours after device removal, 0.025 mg of GnRH was administered to induce ovulation ( Fig. 1 ) Differences regarding hormonal protocol for superovulated cows are based on the achievement of more synchronous ovulations (Baruselli et al. 2012) . The animals were slaughtered on Day 7 after GnRH administration, the ovaries were collected and the CL was dissected and snapfrozen in liquid nitrogen for later mRNA or protein extraction. Tissue samples were fixed in 4% phosphate-buffered formalin solution and embedded in paraffin for immunohistochemistry and immunofluorescence analyses.
Number and volume of corpora lutea (CLL)
CLL were counted and volume was calculated using the formula for an ellipsoid: (3/4pi (width/2) (height/2) (depth/2)). For superovulated cows three CLL were used to calculate the CL volume.
Progesterone assay P4 concentrations were measured by radioimmunoassay (RIA) using a commercial kit (COAT-A-COUNT Progesterone; Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA). The assay sensitivity was 0.05 ng mL À1 , and the high and low intra-assay coefficients of variation were 2.11% and 5.91%, respectively. The total plasma progesterone concentration was divided by the number of corpora lutea in the superovulated animals.
RNA extraction
Total RNA extraction from superovulated animals was performed using a pool of three CLL from each animal. Trizol reagent (Life Technologies, Carlsbad, CA, USA) was used to extract the total RNA, according to manufacturer's recommendations. The RNA was further purified using an RNAeasy kit with DNase treatment to eliminate genomic contamination (Qiagen, Valencia, CA, USA). The RNA was measured with a NanoDrop 2000 (Thermo Scientific, Hudson, NH, USA) and the purity and integrity of the samples was assessed with the RNA 6000 LabChip using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). For the next steps, only RNA with a RNA integrity number (RIN) of 9 or above was used.
Microarray
The microarray analysis was performed at the McGill University and Génome Québec Innovation Centre, Montreal, Canada. Briefly, target RNA was reverse transcribed into cDNA using a T7 oligo(dT) primer (Affymetrix, Santa Clara, CA, USA) to synthesise cDNA containing a T7 promoter sequence. Then, the purified cDNA was used as a template for in vitro transcription to synthesise biotin-modified aRNA with the IVT Labelling Master Mix (Affymetrix), which produced multiple copies of biotin-modified aRNA. The aRNA was purified to remove unincorporated NTPs, salts, enzymes and inorganic phosphate to improve the stability of the biotin-modified aRNA.
The labelled aRNA was then fragmented and hybridised to an Affymetrix GeneChip Bovine Genome Array (Affymetrix, Santa Clara, CA, USA) containing 23 000 probesets and scanned in a GeneChip Scanner 3000 (Affymetrix). The experiments were performed using three samples from each group. Analysis of the data was performed with the FlexArray Software V1.3 (Genome Quebec Innovation Center, Montreal, QC, Canada; http://genomequebec.mcgill.ca/FlexArray/). Raw fluorescence data were processed and normalised with the affx Bioconductor package Version 1.1.0 (http://bioconductor.org/). Lists of genes having a fold change of $AE1.5 and a P value of #0.05 were generated, and the results were compared between control and stimulated, control and superovulated and stimulated and superovulated cows. Lists of differently expressed genes were analysed using Ingenuity Pathway Analysis 7 software (IPA; Ingenuity Systems, San Francisco, CA, USA; http://www. ingenuity.com/). The IPA interprets data in the context of common molecular networks and biological processes using information present in the literature. The software ranks the networks and biological function according to the number of genes present in each list. The microarray data were deposited in the NCBI gene expression and hybridisation array data repository (GEO, http://www.ncbi.nlm.nih.gov/geo). The entire microarray dataset can be retrieved using the GEO accession number GSE37844.
Quantitative real-time PCR
For validation of microarray data, quantitative real-time PCR (qPCR) was performed to assess the abundance of the following genes: peroxisome proliferator-activated receptor gamma (PPARG), the CD36 molecule (CD36), fatty-acid binding protein 5 (FABP5), cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1), acyl-CoA synthetase family member 2 (ACSF), neutral cholesterol ester hydrolase 1 (NCEH1), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), short (PRLRS) and long (PRLRL) prolactin receptors, follistatin and transforming growth factor b2 (TGFB2). Three other candidate genes related to steroidogenesis, STAR, HSD3B and CYP11A1, were also analysed. All 18 samples were used in those analyses. An aliquot of 1 mg of total RNA was submitted to reverse transcription using SuperScript III (Life Technologies). The resulting cDNA was used in subsequent qPCR reactions using a 7500 real-time PCR system (Life Technologies). The TaqMan chemistry (TaqMan Universal PCR Master Mix; Life Technologies) was used for three transcripts encoding STAR, HSD3B and CYP11A1 and the reference gene a-tubulin, while SYBR Green (SYBR Green; Life Technologies) was used for the remaining transcripts and the reference genes a-tubulin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The primers and probes for all transcripts are described in Table 1 . Common thermal cycling settings were used to amplify each transcript (2 min at 508C, 10 min at 958C then 40 cycles of 15 s at 958C and 60 s at 608C). After the SYBR Green reaction, melting curve analyses were performed to verify product identity by adding a dissociation step to the PCR run (15 s at 958C, 60 min at 608C, 15 s at 958C and 15 s at 608C). To test the efficiency of amplification of primer pairs for each gene, a cDNA pool was made using equal volumes of the cDNA solution from each sample. The cDNA pool was serially diluted from 1 : 2 to 1 : 64 in autoclaved RNase-free water. Efficiency of amplification of target as well as the reference genes was calculated by 'LinRegPCR' (Ramakers et al. 2003) using the slope of the dilution curve. The relative expression was calculated using the Pfaffl equation (Pfaffl 2001).
Immunohistochemistry
Tissue sections from one CL per animal were deparaffinised in xylene and rehydrated in a graded series of ethanol. Antigen retrieval was performed by boiling the sections in sodium citrate buffer (10 mM, pH 6.0) in a microwave for 3 Â 5 min, followed by blocking endogenous peroxidase activity with 1% (v/v) hydrogen peroxide in methanol. Nonspecific binding was blocked by incubating the sections with Protein Block (Dako, Carpinteria, CA, USA) for 30 min. The sections were then incubated with primary antibodies (Table 2 ) overnight at 48C. For HSD3B and P450scc, antibody dilutions of 1 : 200 and 1 : 1000 were used, respectively. Next, the sections were incubated with Dako LSAB System-HRP and the DAB Chromogen System (Dako) according the manufacturer's instructions. The slides were observed with an Olympus BX 50 microscope equipped with a CCD colour video camera (Olympus DP71; Olympus America Inc, Center Valley, PA, USA), and the images were captured using Axio Vision software (Carl Zeiss, Oberkochen, Germany).
Immunofluorescence
The protein localisation of STAR, FABP5, HMGCR and follistatin was verified by immunofluorescence in the CL tissue. Briefly, tissue sections were treated as described above until the blockade step. The sections were blocked in phosphate-buffered saline (PBS) containing 5% bovine serum albumin (BSA) for 30 min at room temperature (RT) followed by incubation with the primary antibody overnight at 48C (Table 2 ). The antibodies were diluted in PBS containing 5% BSA to the following concentrations: STAR 1 : 300, HMGCR 1 : 50, follistatin 1 : 200 and FABP5 1 : 500. As a negative control, sections were incubated 
with BSA instead of the primary antibody. The sections were washed, incubated with Cy3-conjugated donkey anti-rabbit (Millipore, Temecula, CA, USA) diluted 1 : 300 (STAR, HMGCR and FABP5) or fluorescein isothiocyanate (FITC)-conjugated anti-rabbit (1 : 300; Millipore) in PBS for 1 h at RT. The slides were then washed and the sections were counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, St. Louis, MO, USA) diluted 1 : 1000 in PBS and incubated for 5 min. The slides were mounted in Permafluor (Laboratory Vision Corp., Fremont, CA, USA). The CL distribution of each protein was observed by fluorescence microscopy using the Olympus Fluoview 1000 system (Olympus America Inc) and Fluoview Version 1.7 software (Olympus America Inc).
Protein extraction and purification
Protein extraction from superovulated animals was performed using a pool of three CLL from each animal. The CL samples (100 mg) were homogenised in buffer containing 50 mM potassium phosphate (pH 7.0), 0.3 M sucrose, 0.5 mM dithiothreitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA, pH 8.0), 0.3 mM phenylmethylsulfonyl fluoride (PMSF), 10 mM NaF and phosphatase inhibitor cocktail (1 : 100; SigmaAldrich). After centrifugation (20 000g, 5 min, 48C) the supernatant containing the total protein was isolated. Protein levels were determined by the Bradford method (Bradford 1976 ; Protein Assay Kit; Bio-Rad Laboratories, Hercules, CA, USA), comparing the measurements obtained for samples with the standard curve of albumin read at 595 nm.
Western blot
Western blot analysis was performed to detect and compare the protein content of STAR, HSD3B, FABP5, PPARG, HMGCR, follistatin, PRLRS and PRLRL in all experimental groups. Equal amounts (50 mg) of total protein were resolved on 10-17% one-dimensional SDS-PAGE minigels depending on the protein molecular weight. The separated proteins were electro-transferred to immunoblot polyvinylidene difluoride membranes (Bio-Rad Laboratories). After the transfer the membranes were blocked with 5% non-fat dried milk in PBS-Tween 1% (PBS-T) for 2 h and incubated with primary antibodies ( 
Statistical analysis
The statistical analysis of the microarray data was conducted according to the random variance model of Wright and Simon 
Microarray
The microarray analysis yielded three lists of genes whose expression levels changed at least 1.5-fold (P # 0.05) when groups were analysed by pairs. Overall, 242 transcripts were upregulated and 111 transcripts were downregulated in stimulated cows (P , 0.05) and 111 were upregulated and 113 downregulated in superovulated cows in relation to the control (1.5 fold, P # 0.05). Genes belonging to the three lists and the total number of genes are depicted in a Venn diagram (Fig. 2) .The complete lists of the differently expressed genes are in Table S1 available as Supplementary Material to this paper. The Ingenuity Pathway network functions found in the CL of stimulated animals are related to cell death, carbohydrate and lipid metabolism and tissue development. In the case of superovulated animals, the networks were related to cell-to-cell signalling, the inflammatory response, cell morphology, the cell cycle, cell growth and proliferation and lipid metabolism. The main network functions involving the genes that were differently expressed between the stimulated and superovulated animals were related to lipid metabolism, post-translational modification, cell death, cell-tocell signalling and protein folding.
Real-time qPCR validation
Most of the genes selected for qPCR analyses were related to lipid metabolism. Among them, CD36, CYP27 and ASCF2, which participate in PPAR pathways, were upregulated in the stimulated animals compared with controls. PPARG and FABP5, which also participate in PPAR pathways, were upregulated in both the stimulated and superovulated groups compared with the control. HMGCR and NCHI, participants in cholesterol metabolism were, respectively, up-and down-regulated in stimulated and superovulated cows in relation to control (Fig. 3) . In the next step, genes belonging to different pathways related to progesterone production and CL development were also analysed. The PRLRs and TGFB2 were upregulated in stimulated cows compared with control and follistatin was upregulated in both groups, stimulated and superovulated (Fig. 4) .
In the stimulated animals, the expression ratios obtained by qPCR were consistent with the microarray results (Figs 3 and 4) . For superovulated animals, the discrepancy between the results was greater, most likely due to the large individual variability in response to the treatment. With respect to the expression of follistatin, no difference between superovulated and control animals was observed using microarray analysis, whereas the relative abundance of this transcript was increased in superovulated animals compared with control when analysed by qPCR (P , 0.05). The stimulated and superovulated animals showed increased expression of HMGCR (Fig. 3) compared with control animals, although according to the microarray results, no difference was observed in the superovulated animals (Table 3) . Three important transcripts (HSD3B, CPY11A1 and STAR) related to luteal steroidogenesis, which showed no significant differences in expression in the microarray analysis, were also analysed by qPCR. No significant differences in mRNA levels were detected for HSD3B or CPY11A1 but the expression of the STAR gene was increased in stimulated and superovulated (P , 0.05; Fig. 5 ) compared with control animals.
Protein localisation
HSD3B immunostaining was restricted to the cytoplasm of small and large luteal cells, exhibiting the same intensity in all groups (Fig. 6 ). For the P450scc protein, expression was also observed in the cytoplasm of both luteal cell populations; however, its expression seemed to be increased in the small luteal cells of the treated groups. No positive staining could be observed in the endothelial or stroma cells of any of the studied groups (Fig. 6 ). For STAR, FABP5 and HMCGR immunostaining a secondary antibody conjugated with the fluorophore CY3 was used and positive immunostaining was observed in the cytoplasm of small and large luteal cells. STAR and FABP5 immunostaining was more evident in luteal cells from the stimulated and superovulated groups, whereas HMGCR did not show any signal intensity difference among the groups (Fig. 7) . Follistatin was detected in the small and large luteal cells from all animals and the staining signal appeared to be greater in the cells from the stimulated and superovulated animals in relation to the control group (Fig. 7) . No positive staining was observed in the negative control for any of the proteins under study (Figs 6 and 7) .
Protein levels assessed by western blot
Western blot analysis was performed to determine the association between the abundance of STAR, HSD3B, PPARG, follistatin, HMGCR, PRLRS, PRLRL and FABP5 proteins and mRNA abundance. The relative expression levels of these proteins were calculated by normalising the results to ACTB (42 kDa). For STAR (Fig. 8b) , a specific band of 31 kDa was observed and its expression was higher in stimulated and superovulated animals compared with controls (P , 0.05). HSD3B (Fig. 8a) corresponds to a 30-kDa band and its levels were not different among the groups. The immunoblots for PPARG, HMGCR and FABP5 proteins revealed bands at 52, 55 and 15 kDa, respectively. Densitometric analysis indicated an increase of the three proteins in the corpora lutea of stimulated and superovulated cows compared with controls (P , 0.05; Fig. 9 ). PRLRS and PRLRL were detected using the same antibody, which detected bands at ,40 and 100 kDa, respectively. The relative expression of PRLRS showed a significant increase in the stimulated and superovulated groups; however, PRLRL was only increased in the stimulated group (P , 0.05; Fig. 10a,b) . Follistatin comprised two bands of ,55 kDa showing increased expression in stimulated and superovulated groups compared with the control (P , 0.05; Fig. 10c ).
Discussion
In the present study we successfully identified many differentially expressed genes in the CL from stimulated and superovulated cows in relation to each other and to control cows. Based on the biological functions and, in particular, the process of steroidogenesis, genes regulated by eCG treatment were selected. It is important to highlight that eCG treatments were conducted in the follicle and we analysed the subsequently formed CL, indicating that observed alteration in luteal cell machinery may be due to residual activity of eCG for several days and even to the reprogramming of the follicle, which rendered a more steroidogenic CL. We observed that CL volume was higher in superovulated than in stimulated cows and higher in stimulated than in the control cows, and the P4 concentration was higher in stimulated animals than in control cows. Furthermore, protocols using gonadotrophins to stimulate the largest follicles consistently result in increased plasma progesterone concentrations (Nogueira et al. 2004; Souza et al. 2009; Sá Filho et al. 2010) . Thus, according to the literature and our own findings, we chose to explore the pathways that might elucidate the regulatory mechanisms that are affected by eCG in luteal cells. Considering the augmentation of progesterone levels in stimulated animals, i.e. in recipient cows for fixed-time embryo transfer, the first step was to verify the expression of key factors related to steroidogenic activity. We observed that both STAR protein and mRNA expression were upregulated by eCG in stimulated and superovulated animals, which most likely contributed to the increase in P4 concentrations because STAR is considered to be the rate-limiting step in steroid biosynthesis (Lin et al. 1995; Stocco and Clark 1996; Strauss et al. 2003; Miller 2007) . Furthermore, although small and large luteal cells show intense P450scc and HSD3B activity (Wiltbank et al. 1993; Belfiore et al. 1994) , none of these enzymes appeared to be altered by eCG.
The main function of any steroid-producing cell is to maintain a supply of cholesterol, and, in this context, most of the genes that were selected for qPCR validation are related to lipid biosynthesis and belong to the PPARG pathway. PPARG regulates the transcription of several target genes involved in ovarian functions, such as STAR and steroidogenesis (SetoYoung et al. 2007) , ovulation, oocyte maturation and CL maintenance (Komar 2005) . PPARG is active in several metabolic pathways, including lipid and cholesterol metabolism, and it is considered to be the key regulator of lipid cellular homeostasis (Varga et al. 2011) . In our study, the PPARG gene and protein expression levels were higher in eCG-treated cows than in non-treated cows, indicating that this transcription factor might participate in the activation of STAR expression and also that of genes related to lipid metabolism in the CL from eCGtreated cows. Among the other PPARG target genes involved in lipid metabolism and regulated by eCG treatment are CD36, FABP5, CYP27A1 and ACSF2. CD36 is a multifunctional scavenger receptor that mediates endocytosis or selective cholesterol uptake from oxidised LDL and HDL lipoproteins. It is upregulated in bovine pre-ovulatory follicles in response to the LH surge (Li et al. 2009 ). CD36 gene expression was increased only in eCG-stimulated cows and it may increase progesterone output in these animals by increasing the levels of available substrate. FABP5 was the most extensively upregulated of the differentially expressed genes in stimulated animals and it was also increased in superovulated CLs. FABP5 is a lipid carrier related to PPARG. It further transports lipids to droplets for storage, to the endoplasmic reticulum for signalling or to the mitochondria for oxidation (Haunerland and Spener 2004; Chmurzyńska 2006; Furuhashi and Hotamisligil 2008) . Additionally, FABP5 gene knockdown results in decreased cholesterol and cholesterol ester levels in ARPE-19 cells (Wu et al. 2010 ) and FABP5 levels have been shown to increase in rat ovaries after hCG induction of ovulation (Hennebold 2004) . These findings point to new insights into the potential role of FABP5 in CL function, which might be related to the supply or transport of cholesterol and other lipids. The other two analysed genes participating in lipid metabolism were CYP27 and ACSF2, and the mRNA abundance of both genes was upregulated in the CLs of stimulated cows compared with control ones. CYP27 catalyses the synthesis of 27-hydroxycholesterol, which may be regulated by steroidogenic activity in ovarian cells to ensure the availability of steroid hormone precursors (Rennert et al. 1990 ). On the other hand, ACSF2 belongs to the long-chain acyl-CoA synthetase family and catalyses the synthesis of acyl-CoA, a substrate entering numerous pathways including that of de novo synthesis of fatty acids, synthesis of triacylglycerol and phospholipids, b-oxidation, and cholesterol esterification (Coleman et al. 2002) . Based on these findings, a local lipid metabolism regulatory mechanism may exist in the bovine CL, and it might be enhanced by eCG, improving the efficiency or magnitude of steroid synthesis. Additionally or alternatively, de novo synthesis of cholesterol may be a further means of increasing cholesterol availability for luteal steroidogenesis. HMGCR is the rate-limiting enzyme in this process (Gwynne and Strauss 1982) . Its gene and protein expression were both upregulated in the CLL of stimulated and superovulated animals and it has been reported that FSH increases HMGCR expression in granulosa cells (Liu et al. 2009 ). HMGCR activity is usually regulated by a negative feedback mechanism and it involves sterol regulation of its gene promoter (Golos and Strauss 1988) . Thus, the regulation of progesterone production in the CL by eCG treatment appears to be mediated, at least in part, by increases in HMGCR expression and cholesterol synthesis.
Interestingly, our study showed a lower expression of NCEH1 in corpora lutea of eCG-treated cows. NCEH1 is important for the hydrolysis of cholesterol esters found in lipid droplets and its activity can be regulated within steroidogenic tissues by hormones including FSH, LH and hCG (Trzeciak et al. 1984; Kraemer et al. 1993) . However, NCEH1 is not dynamically regulated in luteal cells and therefore it may not limit steroidogenesis. Targeted deletion of the NCEH gene does not result in accumulated cholesterol esters in steroidogenic cells, suggesting the existence of alternative genes encoding cholesterol esterase activity (Chung et al. 2001) .
Another upregulated gene of particular interest was PRLR because prolactin (PRL) can affect luteal progesterone production (Stocco 2012 ) and also regulate cell differentiation and proliferation in diverse tissues (Bole-Feysot et al. 1998) . While the evidence for a role for PRL in the bovine ovary is controversial, in rodents, where the requirement for luteal prolactin stimulation is well established, CL cells from PRLR knockout mice failed to organise appropriately and underwent dramatic apoptosis (Grosdemouge et al. 2003) . The PRLRS and PRLRL mRNA and protein levels were upregulated in stimulated animals, whereas only the PRLRS protein was increased in superovulated animals. These results point towards a possible role of eCG in the regulation of PRLR expression and they suggest that the expression of each PRLR isoform can be regulated independently (Picazo et al. 2004) . Furthermore, the increase in PRLRS expression in superovulated animals could be related to its action on cell proliferation and angiogenesis (Bole-Feysot et al. 1998; Stocco 2012) , whereas the increase of PRLRL in stimulated animals could be related to prolactin's effect on luteal progesterone production (Stocco 2012) .
To gain more insights regarding the influence of eCG on CL function, the follistatin and TGFB2 genes were also analysed. Follistatin can modulate the function of granulosa cells in favour of luteinisation and may also directly modulate luteal progesterone production (Findlay 1993; Hillier and Miró 1993; Kaipainen et al. 1995) . Moreover, in cows, the dominant follicle contained more follistatin than the corresponding subordinate follicles, and, in the CL, the highest expression of follistatin was detected on the day of maximum CL activity (Singh and Adams 1998) . The eCG treatment upregulated follistatin gene and protein expression in stimulated and superovulated animals, suggesting that follistatin could be involved in the final stages of follicle and luteal development in the eCG-treated animals. TGFB2 is a multifunctional growth factor that mediates several physiological processes related to cellular function (Roberts and Skinner 1991) , such as follicle growth, cell proliferation and enhanced formation of the extracellular matrix (Lawrence 1996) . In the CL, TGFB2 is mainly expressed by small luteal cells (Sriperumbudur et al. 2010) and macrophages (Matsuyama and Takahashi 1995) . Moreover, TGFB2 mediates the luteotrophic action of prolactin in the rat CL (Matsuyama and Takahashi 1995) and is able to increase progesterone production by theca cells in cattle (Roberts and Skinner 1991) . Indeed, the specific function of TGFB2 in the bovine CL is not well established. Here, TGFB2 gene expression was upregulated in the CL from eCG-stimulated animals, and these results provide additional information about the possible involvement of TGFB2 in bovine CL growth and remodelling under regulation of eCG.
In summary, our findings provide important insights into potential eCG targets during bovine CL development, maintenance and progesterone production. Equine CG stimulated the expression of steroidogenic proteins such as STAR, as well as the regulation of cholesterol biosynthesis and structural-related genes. Differential expression of these genes is proposed as an important cause that leads to an increase of CL volume and improvement in luteal progesterone production.
